Latest news
Enterprise value to revenue forward of Pharmacorp Rx Inc Warrant 2025-12.11.2027 on Pharmacorp – TSXV:PCRX.WT - TradingViewTradingView · Sat, 08 Aug 2026 10:07:02 GMTRecursion Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Wed, 05 Aug 2026 19:04:02 GMTRXRX: Lowered 2026 OpEx by 40% and advanced five clinical programs, validating the AI-native engine - TradingViewTradingView · Wed, 05 Aug 2026 14:23:04 GMTRXRX: Reduced 2026 cash opex guidance, strong cash runway, and major clinical milestones achieved - TradingViewTradingView · Wed, 05 Aug 2026 13:02:44 GMTRXRX: Revenue fell sharply but net loss narrowed on lower expenses; cash runway remains solid - TradingViewTradingView · Wed, 05 Aug 2026 10:43:48 GMTRXRX: AI-driven drug discovery advances with strong cash position and key clinical milestones ahead - TradingViewTradingView · Wed, 05 Aug 2026 10:43:26 GMTRecursion Pharmaceuticals 2026: Revenue $7.67M, EPS ($0.25) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 10:41:02 GMTRXRX Q2'26 Earnings: EPS estimate is (0.24) USD - TradingViewTradingView · Tue, 04 Aug 2026 11:01:05 GMT